These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1994484)

  • 1. Loss of maternal measles antibody in black South African infants in the first year of life--implications for age of vaccination.
    Kiepiela P; Coovadia HM; Loening WE; Coward P; Abdool Karim SS
    S Afr Med J; 1991 Feb; 79(3):145-8. PubMed ID: 1994484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of countermeasures on measles control in infants].
    Wang L; Sun L; Jiang Z; Kang S; Liu Y; Jiang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):49-50. PubMed ID: 11860845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.
    Leuridan E; Hens N; Hutse V; Ieven M; Aerts M; Van Damme P
    BMJ; 2010 May; 340():c1626. PubMed ID: 20483946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules.
    de Francisco A; Hall AJ; Unicomb L; Chakraborty J; Yunus M; Sack RB
    Vaccine; 1998 Apr; 16(6):564-8. PubMed ID: 9569466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamic maternal measles antibody level in infants: a longitudinal study].
    Lu L; Cao YM; Yang QY; He Q; Dong ZQ; Di B; Fu CX; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):663-7. PubMed ID: 27188358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study.
    Gieles NC; Mutsaerts EAML; Kwatra G; Bont L; Cutland CL; Jones S; Moultrie A; Madhi SA; Nunes MC
    Clin Microbiol Infect; 2020 Apr; 26(4):515.e1-515.e4. PubMed ID: 31730905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
    Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of maternal measles antibody during infancy in an African city.
    Dabis F; Waldman RJ; Mann GF; Commenges D; Madzou G; Jones TS
    Int J Epidemiol; 1989 Mar; 18(1):264-8. PubMed ID: 2722375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of maternally derived antibody against measles: a seroepidemiological study of infants aged under 8 months in Qinghai, China.
    Zhang X; Shirayama Y; Zhang Y; Ba W; Ikeda N; Mori R; Shibuya K
    Vaccine; 2012 Jan; 30(4):752-7. PubMed ID: 22133513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of passive measles antibody in Jamaican children.
    Christie CD; Lee-Hirsh J; Rogall B; Merrill S; Ramlal AA; Karian V; Black FL
    Int J Epidemiol; 1990 Sep; 19(3):698-702. PubMed ID: 2262267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
    Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
    Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity.
    Maldonado YA; Lawrence EC; DeHovitz R; Hartzell H; Albrecht P
    Pediatrics; 1995 Sep; 96(3 Pt 1):447-50. PubMed ID: 7651776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children.
    Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Boyce W; Jose L; Koen A; Moultrie A; Cutland CL; Grobbee DE; Klipstein-Grobusch K; Madhi SA
    J Infect Dis; 2019 Sep; 220(9):1529-1538. PubMed ID: 31282539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining infants' age for measles vaccination based on persistence of protective level of maternal measles antibody.
    Shilpi T; Sattar H; Miah MR
    Bangladesh Med Res Counc Bull; 2009 Dec; 35(3):101-4. PubMed ID: 20922913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum age for measles immunization in Romania.
    Biberi-Moroeanu S; Tiţeica-Boldeanu M; Munţiu A; Petrenco M; Suter C
    Virologie; 1986; 37(1):3-8. PubMed ID: 3962178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.
    Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P
    Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.
    Nicoara C; Zäch K; Trachsel D; Germann D; Matter L
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):868-71. PubMed ID: 10548578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.